Loading...
White matter changes in patients with Friedreich ataxia after treatment with erythropoietin
BACKGROUND AND PURPOSE: Erythropoietin (EPO) has received growing attention because of its neuro-regenerative properties. Preclinical and clinical evidence supports its therapeutic potential in brain conditions like stroke, multiple sclerosis and schizophrenia. Also in Friedreich ataxia, clinical im...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2013
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3950637/ https://ncbi.nlm.nih.gov/pubmed/24015771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jon.12050 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|